Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04904107
Other study ID # Study number 2021_002
Secondary ID NL71820.096.19
Status Recruiting
Phase N/A
First received
Last updated
Start date July 4, 2021
Est. completion date June 1, 2024

Study information

Verified date June 2022
Source VieCuri Medical Centre
Contact Lisa Frenk, Drs.
Phone 0031773205555
Email lfrenk@viecuri.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multicenter, prospective, investigator-initiated, randomized controlled trial aiming to reduce the percentage of non-cardiac chest pain (NCCP) patients admitted to the cardiac emergency department (ED) by performing the modified HEART score by emergency medical transport (EMT) personnel.


Description:

Patients with acute coronary syndrome (ACS) should be referred to the hospital promptly. However, referring all patients with chest pain is not feasible, as recent studies showed that up to 80% of the patients with acute chest pain do not have ACS. Bedside point-of-care (POC) high sensitive troponin testing (in fingerprick blood/capillary blood) and the modified HEART score have become available and might play a substantial role in the triage and diagnosis of chest pain patients in a pre-hospital setting by general practitioners (GPs) and EMT personnel in the future. We hypothesize that patients with chest pain can be referred more accurately by using the modified HEART score.


Recruitment information / eligibility

Status Recruiting
Enrollment 852
Est. completion date June 1, 2024
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years. - Chest pain or other complaints suspect of ACS for at least 2 hours where the GP or emergency medical personnel are in need of further diagnostics or risk stratification to come to a decision of referral. - Patients, who have been informed of the nature of the study, agree to its provisions and have provided written informed consent. Exclusion Criteria: - Electrocardiographic ST-segment elevation/High suspicion of STE-ACS. - Suspicion of an acute non-coronary diagnosis e.g. pulmonary embolism, thoracic aortic dissection or other life-threatening disease. - Patients presenting cardiogenic shock, defined as: systolic blood pressure <90mmHg and heart rate >100 and peripheral oxygen saturation <90% (without oxygen administration) - Patients presenting with sudden onset heart rhythm disorders and second or third degree atrioventricular block. - Patients with confirmed ACS, PCI or CABG <30 days prior to inclusion. - Impaired consciousness defined as an EMV <8. - Severe shortness of breath. - Patients with known end-stage renal disease (dialysis and/or MDRD < 30 ml/min). - Patients with known cognitive impairment. - Communication issues with patient/language barrier. - Patients already participating in an interventional cardiology or cardiovascular trial.

Study Design


Intervention

Diagnostic Test:
modified HEART score (including POC hs cTnI analysis)
The modified HEART score was developed in 2007 and has been validated to stratify the risk of short-term adverse cardiac events in patients with chest pain at the ED. Negative predictive value (NPV) of the modified HEART score for ACS as well as positive predictive value (PPV) for major adverse cardiac events (MACE) within 6 weeks after presentation is high. The modified HEART score is an acronym for history, ECG, age, risk factors and troponin at arrival.The components can be rated 0,1 or 2 points each and result in a total score between 0 and 10.
Other:
Standard care and triage according to the local (EMT)protocol.
Standard care and triage of chest pain patients according to the local (EMT)protocol.

Locations

Country Name City State
Netherlands Laurentius Hospital Roermond Roermond Limburg
Netherlands Viecuri Medical Centre Northern Limburg Venlo Limburg

Sponsors (2)

Lead Sponsor Collaborator
VieCuri Medical Centre Siemens Healthineers Nederland B.V.

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of non-cardiac chest pain (NCCP) patients admitted at the cardiac ED (percentage, %) Evaluation of the percentage of NCCP patients admitted to the cardiac ED by performing the modified HEART score in comparison to our control group (regular triage and care). We aim to detect a reduction of minimal 10% in unnecessarily referred chest pain patients (NCCP patients) but expect an even higher percentage. A lower percentage of NCCP patients indicates improval of the triage of chest pain patients. 30 days
Primary The incidence of MACE (percentage, %) The mortality and major adverse cardiovascular events (MACE) i.e. acute myocardial infarction, non-elective percutaneous coronary intervention, coronary artery bypass grafting or all cause death within 30 days, 6 months and 1 year after initial presentation in the intervention group versus control group.
We aim that the proportion of MACE in the intervention group (modified HEART score) is non-inferior to the control group (regular care and triage). Preliminary results of the second phase of FAMOUS Triage trial showed 15.7% (13.1-18.6) MACE rate.We used the expected incidence of 15.7% as the point estimate (meaning no difference between control and intervention). A higher MACE rate (%) in the intervention group suggests a worst outcome.
30 days, 6 months and 1 year
Secondary The incidence of MACE in subgroups (percentage, %) Prespecified subgroup analyses of primary outcomes will be performed for:
Diabetic patients versus non-diabetic patients.
Male versus female patients
Patients referred by GP versus patient referred by triage nurse at GP cooperatives (GPC) versus self referrals.
30 days, 6 months and 1 year
Secondary The incidence of non-cardiac chest pain (NCCP) patients admitted at the cardiac ED in subgroups (percentage, %) Prespecified subgroup analyses of primary outcomes will be performed for:
Diabetic patients versus non-diabetic patients.
Male versus female patients
Patients referred by GP versus patient referred by triage nurse at GP cooperatives (GPC) versus self referrals.
30 days, 6 months and 1 year
Secondary Cost-effectiveness analysis This economic evaluation investigates the health care costs of full implementation of a prehospital rule- out strategy with the modified HEART score (intervention group) compared with regular care and standard transfer to the hospital to rule out ACS (control group). Health-care costs will be prospectively recorded at baseline and at 30 days follow-up, 6 months and 1 year. This includes health care costs due to readmission, diagnostic testing, revascularization etc. The cost of hospital treatment is determined by the Dutch Diagnose Behandel Combinatie (DBC) hospital reimbursement system and the DBC information system, similar to the international diagnosis related group system. 30 days, 6 months and 1 year
Secondary Assessment of the diagnostic value of the modified HEART score. Positive Predictive Value (PPV), sensitivity, specificity and Negative Predictive Value (NPV) of the modified HEART score for ACS will be calculated. 30 days, 6 months and 1 year
Secondary Overview of the actual diagnosis of patients with a low modified HEART score (0-3). To evaluate the percentage of patients in this specific group with ACS versus no-ACS. 30 days
Secondary Overview of the actual diagnosis of patients with moderate-high modified HEART score (>3). To evaluate the percentage of patients in this specific group with ACS versus no-ACS. 30 days
Secondary Clinical accuracy POC hs cTnI. Clinical accuracy (Positive Predictive value) of POC hs cTnI assessment versus hs cTnT at the cardiac ED. 30 days
Secondary Time analysis. Time elapsed from arrival EMT at patient's home to arrival at ED in intervention group versus control group. 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Completed NCT04507529 - Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients N/A
Recruiting NCT06066970 - Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Recruiting NCT03620266 - Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI N/A
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT03668587 - Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Recruiting NCT05371470 - Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation N/A
Recruiting NCT04562272 - Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT06007950 - Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health N/A
Withdrawn NCT05327855 - Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) Phase 2
Recruiting NCT02876952 - High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients N/A
Completed NCT02711631 - Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation N/A
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02305602 - A Study of VentriGel in Post-MI Patients Phase 1
Completed NCT02382731 - Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction N/A